These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. [Ether derivatives of 3-amino-1,2-propanediol, II: synthesis and pharmacological investigation of n-substituted derivatives of 1-cycloalkyloxy-3-amino-2-propanols (author's transl)]. Dantschev D; Georgiev A; Tschalina E; Dobreva-Usunova D; Staneva D Arch Pharm (Weinheim); 1979 Oct; 312(10):857-63. PubMed ID: 44460 [No Abstract] [Full Text] [Related]
11. 2-(Isoxazolylethenyl)phenoxypropanolamines: a new class of beta-receptor antagonists with antihypertensive activity. Franke A; Frickel FF; Gries J; Lenke D; Schlecker R; Thieme PD J Med Chem; 1981 Dec; 24(12):1460-4. PubMed ID: 6118439 [TBL] [Abstract][Full Text] [Related]
12. A new series of cardioselective adrenergic beta-receptor blocking compounds. 1-(2-Acyl-4-acylaminophenoxy)-3-isopropylaminopropan-2-ols. Basil B; Clark JR; Coffee EC; Jordon R; Loveless AH; Pain DL; Wooldridge KR J Med Chem; 1976 Mar; 19(3):399-402. PubMed ID: 3647 [TBL] [Abstract][Full Text] [Related]
13. Ether derivatives of 3-amino-1,2-propanediols, IV. Syntheses and pharmacological investigations of 1-cycloalkoxy-3-amino-2-propanols and 1-cycloalkoxy-3-guanidino-2-propanols. Chalina E; Dantchev D; Georgiev A; Staneva D Arch Pharm (Weinheim); 1984 Jan; 317(1):63-9. PubMed ID: 6142704 [No Abstract] [Full Text] [Related]
14. Quantitative structure-activity relationships. Fujita-Ban analysis of beta-adrenergic blocking activity of 1-phenoxy-3-([(substituted amido)alkyl]amino)-2-propanols. Gombar V Arzneimittelforschung; 1986 Jul; 36(7):1014-8. PubMed ID: 2876713 [TBL] [Abstract][Full Text] [Related]
15. Beta-adrenoceptor blocking agents. 1. Cardioselective 1-aryloxy-3-(aryloxyalkylamino)propan-2-ols. Augstein J; Cox DA; Ham AL; Leeming PR; Snarey M J Med Chem; 1973 Nov; 16(11):1245-51. PubMed ID: 4147835 [No Abstract] [Full Text] [Related]
16. beta 1-selective adrenoceptor antagonists. 1. Synthesis and beta-adrenergic blocking activity of a series of binary (aryloxy)propanolamines. Kierstead RW; Faraone A; Mennona F; Mullin J; Guthrie RW; Crowley H; Simko B; Blaber LC J Med Chem; 1983 Nov; 26(11):1561-9. PubMed ID: 6138434 [TBL] [Abstract][Full Text] [Related]
17. Beta-adrenergic blocking agents: substituted phenylalkanolamines. Effect of side-chain length on beta-blocking potency in vitro. Fuhrer W; Ostermayer F; Zimmermann M; Meier M; Müller H J Med Chem; 1984 Jul; 27(7):831-6. PubMed ID: 6145802 [TBL] [Abstract][Full Text] [Related]
18. 1-Alkylamino-3-(2-thiazolyloxy)-2-propanols. A novel class of mixed myocardial beta-stimulants-beta-blockers. Edwards JA; Berkoz B; Lewis GS; Halpern O; Fried JH; Strosberg AM; Miller LM; Urich S; Liu F; Roszkowski AP J Med Chem; 1974 Feb; 17(2):200-3. PubMed ID: 4148933 [No Abstract] [Full Text] [Related]
19. Synthesis of a novel series of (aryloxy)propanolamines: new selective beta 2-blocking agents. Carre MC; Youlassani A; Caubere P; Saint-Aubin-Floch A; Blanc M; Advenier C J Med Chem; 1984 Jun; 27(6):792-9. PubMed ID: 6145801 [TBL] [Abstract][Full Text] [Related]
20. Derivatives of 3,4-dihydrocarbostyril as beta-adrenergic blocking agents. Nakagawa K; Murakami N; Yoshizaki S; Tominaga M; Mori H J Med Chem; 1974 May; 17(5):529-33. PubMed ID: 4151493 [No Abstract] [Full Text] [Related] [Next] [New Search]